课题基金 / 基金详情

Postdoctoral Training Program in Pulmonary and Critical Care Translational Research

Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
批准号:
10472480
负责人:
STEVEN M DUDEK
金额:
$23.74万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2024-06-30

项目摘要

项目成果

STEVEN M DUDEK的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 我们热情地提交了修改后的申请,申请我们在伊利诺伊大学的T32培训计划 芝加哥(UIC)名为肺和重症监护翻译博士后培训计划 研究。我们计划的主要目标是下一代科学领袖的职业发展 在肺和重症护理医学领域,沿着三条综合专题路径提供 全面培训1)肺损伤和炎症,2)精确医学和计算方法, 3)比较有效性与健康不平等。这一创新的新计划建立在我们的经验基础上 并在最近10年内取得了成功,之前在我们的分部拥有博士后T32 肺,重症监护,睡眠和过敏。这个先前的项目有一个突出的成功轨迹, 我们最近的T32学员仅在过去两年就获得了3个新的K08,1个K23和1个R01。此外,13人出局 在我们先前项目的最后18名T32研究员中,他们继续追求以科学为导向的职业。有了这个新的 计划,我们在这令人印象深刻的成功历史的基础上,大幅推进和扩大了我们的 通过招聘多名新教员创造培训环境。他们的各个科学领域的增加 专业知识为我们的培训环境带来了新的最先进的维度。我们的基本前提和 统一的假设是,一个专注于尖端研究方法的综合计划将 激励新一代在肺部疾病领域取得成功的科学领袖。具有频繁的输入和反馈 从教职员工、实习生到内部和外部顾问,我们不断加强和改进我们的培训计划 以优化我们学员的职业发展和科学成就。中的主要编程增强 这一新计划包括以下内容: 学院的扩大和发展增加了多个新领域的培训机会-肺 微生物组,结节病,肺癌,精确医学,计算建模,医疗保健设计, 人口健康科学 过渡到多PI领导结构,以优化计划监督和增长 对当前培训时间表和学员里程碑的详细说明 成立少数族裔咨询委员会 将以前的T32实习生和初级教员纳入该计划,作为“近距离同行”顾问 要求对T32学员进行科学严谨性和重复性方面的培训 扩大了教职员工所需的年度导师培训 成立了博士培训委员会,以加强博士候选人的招聘和培训 “360度评估”,重点是在年度务虚会上审查当前和以前的实习生计划 候选人将被接受2-3年的研究培训,基于特殊的个人资质。
英文摘要
Project Summary/Abstract We enthusiastically submit this revised application for our T32 training program here at the University of Illinois at Chicago (UIC) entitled Postdoctoral Training Program in Pulmonary and Critical Care Translational Research. The primary goal of our program is the career development of the next generation of scientific leaders in the fields of pulmonary and critical care medicine along three integrated thematic pathways that provide comprehensive training in 1) Lung Injury and Inflammation, 2) Precision Medicine and Computational Approaches, and 3) Comparative Effectiveness and Health Inequality. This innovative new program builds upon our experience and success achieved over a recent 10 year period with a prior postdoctoral T32 based here in our Division of Pulmonary, Critical Care, Sleep, and Allergy. This prior program had an outstanding trajectory of success, with our recent T32 trainees earning 3 new K08s, 1 K23, and 1 R01 in the past two years alone. Moreover, 13 out of the last 18 T32 fellows in our prior program continue to pursue scientifically-oriented careers. With this new program, we build upon this impressive history of success and have substantially advanced and expanded our training environment through the recruitment of multiple new faculty. The addition of their various areas of scientific expertise brings new state-of-the-art dimensions to our training environment. Our underlying premise and unifying hypothesis is that an integrated program focused on cutting-edge research approaches will inspire a new generation of successful scientific leaders in lung diseases. With frequent input and feedback from faculty, trainees, and internal and external advisors, we continually enhance and improve our training program to optimize the career development and scientific success of our trainees. Major programmatic enhancements in this new program include the following:  Faculty expansion and development have added training opportunities in multiple new fields—lung microbiome, sarcoidosis, lung cancer, precision medicine, computational modeling, healthcare design, population health science  Transition to a multi-PI leadership structure to optimize program oversight and growth  Detailed description of current training timeline and trainee milestones  Formation of a Minority Advisory Committee  Incorporation of former T32 trainees and junior faculty into the program as “near peer” advisors  Required training in scientific rigor and reproducibility for T32 trainees  Expanded annual training in mentorship that is required for faculty  Incorporation of a PhD Training Committee to enhance recruitment and training of PhD candidates  “360 degree evaluation” with emphasis on current and former trainee program reviews at annual retreat Candidates will be accepted for 2-3 years of research training based on exceptional personal qualifications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury
Patient Sampling and Genomics Core
Patient Sampling and Genomics Core
Fostering Academic Physician-Investigators Treating High Risk Populations
国内基金
海外基金
胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
  • 批准号:
    30470854
  • 项目类别:
    面上项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2004
  • 负责人:
    陶涛
  • 依托单位: